Workup for Inflammatory Arthritis
The workup for inflammatory arthritis should include rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA), ESR and CRP, x-rays of hands/wrists/feet, and a focused history and physical examination targeting specific prognostic features—this evidence-based approach predicts both diagnosis and prognosis while guiding early treatment decisions.
Essential Laboratory Testing
Obtain RF and/or ACPA testing immediately as these are the most predictive markers for rheumatoid arthritis diagnosis and prognosis 1. The evidence is compelling: both markers strongly predict progression to RA and worse radiographic outcomes. However, a critical caveat—negative RF and ACPA do not exclude progression to RA, so clinical judgment remains paramount 1.
Measure ESR and CRP at baseline for both diagnostic and prognostic value 1. While CRP alone is a poor predictor of persistent arthritis or radiological progression, elevated CRP (especially higher levels) does help predict RA development. Repeat these inflammatory markers when clinically relevant to track disease activity 1.
If connective tissue disease or systemic inflammatory disorder is suspected based on clinical features, add:
- Antinuclear antibodies (ANA)
- Antibodies to extractable nuclear antigens
- Anti-double-stranded DNA antibodies 1
Imaging Studies
X-rays of hands, wrists, and feet should be performed at baseline 1. The presence of erosions is highly predictive for RA development and disease persistence. X-rays of any other affected joints should also be obtained 1. Repeat imaging within 1 year to monitor for radiographic progression 1.
MRI and ultrasound are not recommended for routine use due to insufficient evidence, though MRI of hands and wrists could be considered when RA is specifically suspected 1. The data are too scarce to justify routine advanced imaging despite their superior sensitivity for detecting inflammation and erosions.
Targeted History and Physical Examination
Focus your clinical assessment on these evidence-based predictive features 1:
Demographic factors:
- Age (advanced age predicts RA)
- Gender (female gender predicts RA)
- Geographic area of residence
Symptom characteristics:
- Duration of symptoms ≥6 weeks (predicts persistence)
- Morning stiffness >30 minutes (predicts persistence)
- Functional impairment using standardized assessment
Joint involvement pattern:
- Number of tender and swollen joints (≥3 joints predicts persistence)
- Small joint involvement (hands/feet predicts RA and persistence)
- Knee involvement (predicts persistence)
- Symmetrical pattern (predicts RA)
- Proximal interphalangeal and metatarsophalangeal joint involvement
Additional features:
- Axial/entheseal involvement (suggests spondyloarthritis)
- Extra-articular/systemic features (predict disability)
Additional Testing in Specific Clinical Settings
HLA-B27 testing should be performed when spondyloarthritis is suspected based on axial/entheseal involvement, but genetic testing is not routinely recommended otherwise 1.
Synovial biopsy is not routine but can provide diagnostic information in persistent monoarthritis, suspected malignancy, or chronic infection like tuberculosis 1. This should be ultrasound-guided when performed.
Differential Diagnosis Considerations
Before establishing inflammatory arthritis, systematically exclude:
- Infectious causes (obtain microbiological assessment, including specific serological tests)
- Malignancy
- Crystal arthropathy (urate levels)
- Metabolic disorders (glucose, thyroid function)
- Degenerative disease
- Traumatic causes 1
Obtain complete blood count, comprehensive metabolic panel (liver function, renal function), and urinalysis as baseline screening 1.
Common Pitfalls
The most critical error is assuming negative RF/ACPA excludes inflammatory arthritis—seronegative RA exists and requires the same vigilance 1. Additionally, normal inflammatory markers do not rule out active disease, particularly in early presentations.
Another pitfall: delaying imaging. Erosions at baseline are independent predictors of persistent disease and RA development, making early radiographic assessment essential for prognosis 1.
Prognostic Documentation
Document these predictors of persistent inflammatory arthritis at baseline 1:
- Disease duration ≥6 weeks
- Morning stiffness >30 minutes
- Functional impairment
- Small joint and/or knee involvement
- Involvement of ≥3 joints
- ACPA and/or RF positivity
- Radiographic erosions
This prognostic information guides treatment intensity and monitoring frequency, directly impacting long-term outcomes including joint destruction, disability, and mortality.